Evidence mapPaperPMID 29133954Full record

Trial reportMolecular psychiatry2018

Exogenous ghrelin administration increases alcohol self-administration and modulates brain functional activity in heavy-drinking alcohol-dependent individuals.

M Farokhnia, E N Grodin, M R Lee, E N Oot, A N Blackburn, B L Stangl, M L Schwandt, L A Farinelli, R Momenan, V A Ramchandani and 1 more

Registry-linked trialAbstract readRandomized Controlled Trial
In one paragraph

Trial report in Molecular psychiatry, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT01779024 (Effects of Ghrelin on Alcohol Administration in Non-Treatment Seeking Heavy Drinkers), which is not on this map. Cited by 80 papers, 2 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
80citing papers in PubMed, 2 pooled it
3.6field-weighted citation impact, top 6% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT01779024 phase2completednot on this map

Effects of Ghrelin on Alcohol Administration in Non-Treatment Seeking Heavy Drinkers

TypeinterventionalSponsorNational Institute on Alcohol Abuse and Alcoholism (NIAAA)Ran2012 to 2017Enrolled17ConditionsfMRI, Alcohol Drinking, AlcoholismArmsGhrelin, Placebo, fMRI, Alcohol
3 · Its place in the literature

Who cites it

80 citing papers in PubMed, 2 syntheses or guidelines pooled it, 123 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Trial
  4. Trial
  5. Trial
  6. Trial
  7. Ghrelin decreases sensitivity to negative feedback and increases prediction-error related caudate activity in humans, a randomized controlled trial.Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology · 2024
    Trial
  8. Trial
  9. Trial
  10. Trial
  11. Trial
  12. Trial
  13. Trial
  14. Trial
  15. Trial
  16. Trial
  17. Article
  18. Article
  19. Review
  20. Article

20 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors at 4 institutions in 1 country.

M FarokhniaSection on Clinical Psychoneuroendocrinology and Neuropsychopharmacology, National Institute on Alcohol Abuse and Alcoholism and National Institute on Drug Abuse, National Institutes of Health, Bethesda, MD, USA.
E N GrodinClinical NeuroImaging Research Core, National Institute on Alcohol Abuse and Alcoholism, National Institutes of Health, Bethesda, MD, USA.
M R LeeSection on Clinical Psychoneuroendocrinology and Neuropsychopharmacology, National Institute on Alcohol Abuse and Alcoholism and National Institute on Drug Abuse, National Institutes of Health, Bethesda, MD, USA.
E N OotSection on Clinical Psychoneuroendocrinology and Neuropsychopharmacology, National Institute on Alcohol Abuse and Alcoholism and National Institute on Drug Abuse, National Institutes of Health, Bethesda, MD, USA.
A N BlackburnSection on Clinical Psychoneuroendocrinology and Neuropsychopharmacology, National Institute on Alcohol Abuse and Alcoholism and National Institute on Drug Abuse, National Institutes of Health, Bethesda, MD, USA.
B L StanglSection on Human Psychopharmacology, National Institute on Alcohol Abuse and Alcoholism, National Institutes of Health, Bethesda, MD, USA.
M L SchwandtOffice of the Clinical Director, National Institute on Alcohol Abuse and Alcoholism, National Institutes of Health, Bethesda, MD, USA.
L A FarinelliSection on Clinical Psychoneuroendocrinology and Neuropsychopharmacology, National Institute on Alcohol Abuse and Alcoholism and National Institute on Drug Abuse, National Institutes of Health, Bethesda, MD, USA.
R MomenanClinical NeuroImaging Research Core, National Institute on Alcohol Abuse and Alcoholism, National Institutes of Health, Bethesda, MD, USA.
V A RamchandaniDepartment of Neuroscience, Brown University, Providence, RI, USA.
L LeggioSection on Clinical Psychoneuroendocrinology and Neuropsychopharmacology, National Institute on Alcohol Abuse and Alcoholism and National Institute on Drug Abuse, National Institutes of Health, Bethesda, MD, USA. lorenzo.leggio@nih.gov.
National Institute on Drug Abuse · USNational Institute on Alcohol Abuse and Alcoholism · USBrown University · USNational Institutes of Health · US

Funding

RAT RESEARCH COMPONENTP50AA007611 · INDIANA UNIV-PURDUE UNIV AT INDIANAPOLIS · 1987 to 2002
$5.3M
Alcohol Pharmacokinetics and Pharmacodynamics in HumansZIAAA000466 · NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM · 2025 to 2025
$1.9M
Intramural NIH HHS Z99 DA999999Intramural NIH HHS ZIA AA000218NIAAA NIH HHS P50 AA007611NIAAA NIH HHS ZIA AA000218
6 · The paper itself

Abstract

Preclinical evidence suggests that ghrelin, a peptide synthesized by endocrine cells of the stomach and a key component of the gut-brain axis, is involved in alcohol seeking as it modulates both central reward and stress pathways. However, whether and how ghrelin administration may impact alcohol intake in humans is not clear. For, we believe, the first time, this was investigated in the present randomized, crossover, double-blind, placebo-controlled, human laboratory study. Participants were non-treatment-seeking alcohol-dependent heavy-drinking individuals. A 10-min loading dose of intravenous ghrelin/placebo (3 mcg kg

Indexed as

Administration, IntravenousAdultAlcohol DrinkingAlcoholismAmygdalaBrainCross-Over StudiesDouble-Blind MethodDrug-Seeking BehaviorEthanolFemaleGhrelinHumansMaleMiddle AgedProof of Concept StudyEthanolGhrelin

Identifiers

PMID29133954
PMCPMC12258500
OpenAlexW2770497352

What Socratic holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.